314
Participants
Start Date
July 5, 2017
Primary Completion Date
May 1, 2020
Study Completion Date
May 1, 2020
SOV2012-F1
oral preparation of testosterone undecanoate (TU)
AndroGel
topical testosterone gel 1.62%
Manhattan Medical Research Practice, PLLC, New York
Accumed Research Associates, Garden City
Urologic Consultants of SE Pennsylvania, Bala-Cynwyd
National Clinical Research, Inc., Richmond
Clinical Research Associates of Tidewater, Norfolk
Rapha Institute For Clinical Research, Fayetteville
Coastal Carolina Research Center, Mt. Pleasant
Primary Care Research Group, Atlanta
Jacksonville Impotence Treatment Center, Jacksonville
Oviedo Medical Research, LLC, Oviedo
My Community Research Center, Miami
South Florida Medical Research, Aventura
Health Awareness, Inc., Jupiter
PAB Clinical Research, Brandon
Meridien Research, St. Petersburg
Innovative Research of West Florida, Inc., Clearwater
Meridien Research, Lakeland
Central Research Associates, Inc., Birmingham
Alabama Clinical Therapeutics, LLC, Birmingham
Coastal Clinical Research, Inc., Mobile
University Diabetes Endocrine Consultants, Chattanooga
Central Kentucky Research Associates, Lexington
Aventiv Research, Inc., Columbus
Quality Clinical Research, Inc., Omaha
Centex Studies, Inc., Lake Charles
Centex Studies, Inc., Houston
Pioneer Research Solutions, Inc., Houston
Advanced Clinical Research, Meridian
Northwest Clinical Trials, Boise
Advanced Clinical Research, West Jordan
Quality of Life Medical and Research Centers, LLC, Tucson
Palm Research Center, Inc., Las Vegas
San Diego Sexual Medicine, San Diego
Rainier Clinical Research Center, Inc., Renton
Mid-Columbia Research, Richland
Men's Health Boston, Chestnut Hill
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Marius Pharmaceuticals
INDUSTRY